Evaluation of PD-1 Gene Susceptibility and Prognosis in Breast Cancer Patients in Iranian Population

Programmed cell death-1 (PD1) protein has an inhibitory effect that reduces the activity of T cells. In this study, gene expression PD1 in patients with breast cancer compared to healthy subjects discussed. This study was performed on 25 patients with breast cancer as a case group and 25 healthy individuals as a control group. Real-time PCR method was used to evaluate gene expression. For the case group, the mean age was 2.75 ± 12.18 and for the control group 30.6 ± 2.6. The results of our study showed that the expression of PD1 gene in the case group was higher than the control (p<0.05). As a result of our study show that expression of gene in the development of breast cancer, So PD1 can be used as prognostic gene in breast cancer study be considered. Keywords: Breast cancer, Gene expresion, Programmed cell death-1

Authors

Publication Details

Journal
Journal of Pharmaceutical Research
Published
2024-11-26
DOI
https://doi.org/10.18579/jopcr/v23.3.58
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.28
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of PD-1 Gene Susceptibility and Prognosis in Breast Cancer Patients in Iranian Population

Azade Sarani, Hosnie Hoseini
1 citations
Journal of Pharmaceutical Research
Cancer Immunotherapy and Biomarkers
0.28
article

Evaluation of PD-1 Gene Susceptibility and Prognosis in Breast Cancer Patients in Iranian Population

Azade Sarani, Hosnie Hoseini
article en
1 citations

Abstract

Programmed cell death-1 (PD1) protein has an inhibitory effect that reduces the activity of T cells. In this study, gene expression PD1 in patients with breast cancer compared to healthy subjects discussed. This study was performed on 25 patients with breast cancer as a case group and 25 healthy individuals as a control group. Real-time PCR method was used to evaluate gene expression. For the case group, the mean age was 2.75 ± 12.18 and for the control group 30.6 ± 2.6. The results of our study showed that the expression of PD1 gene in the case group was higher than the control (p<0.05). As a result of our study show that expression of gene in the development of breast cancer, So PD1 can be used as prognostic gene in breast cancer study be considered. Keywords: Breast cancer, Gene expresion, Programmed cell death-1

Journal of Pharmaceutical ResearchVol. 23(3)
Good health and well-being
Openalex Percentile: Top 34%
Cancer Immunotherapy and Biomarkers
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.